142 related articles for article (PubMed ID: 32518748)
1. Low dose intrapleural alteplase and pulmozyme (DNase) in two post-surgical patients with pleural sepsis.
Faisal M; Fazlin M; Ng BH; Nuratiqah N; Andrea YB
Respir Med Case Rep; 2020; 30():101111. PubMed ID: 32518748
[TBL] [Abstract][Full Text] [Related]
2. Short-course modified regimen intrapleural alteplase and pulmozyme (DNase) in pleural infection.
Faisal M; Farhan R; Cheong XK; Ng BH; Nuratiqah N; Andrea Yl B
Respir Med Case Rep; 2020; 31():101168. PubMed ID: 32714827
[TBL] [Abstract][Full Text] [Related]
3. Modified regimen intrapleural alteplase with pulmozyme in pleural infection management: a tertiary teaching hospital experience.
Cheong XK; Ban AY; Ng BH; Nik Abeed NN; Nik Ismail NA; Nik Fuad NF; Syed Zakaria SZ; Ghan SL; Abdul Hamid MF
BMC Pulm Med; 2022 May; 22(1):199. PubMed ID: 35581627
[TBL] [Abstract][Full Text] [Related]
4. Intrapleural hemorrhage due to alteplase use in a 6-year-old boy with pleural effusion.
Hendaus MA; Abushahin A
Int J Gen Med; 2013; 6():233-6. PubMed ID: 23626471
[TBL] [Abstract][Full Text] [Related]
5. The first use of combination of Intrapleural Fibrinolytics (Alteplase & DNAse) for pleural infection in Malaysia.
Muhammad Redzwan SRA
Med J Malaysia; 2019 Apr; 74(2):176-178. PubMed ID: 31079131
[TBL] [Abstract][Full Text] [Related]
6. Alteplase Dose Assessment for Pleural infection Therapy (ADAPT) Study-2: Use of 2.5 mg alteplase as a starting intrapleural dose.
Popowicz N; Ip H; Lau EPM; Piccolo F; Dootson K; Yeoh C; Phu WY; Brown R; West A; Ahmed L; Lee YCG
Respirology; 2022 Jul; 27(7):510-516. PubMed ID: 35441458
[TBL] [Abstract][Full Text] [Related]
7. Dose De-escalation of Intrapleural Tissue Plasminogen Activator Therapy for Pleural Infection. The Alteplase Dose Assessment for Pleural Infection Therapy Project.
Popowicz N; Bintcliffe O; De Fonseka D; Blyth KG; Smith NA; Piccolo F; Martin G; Wong D; Edey A; Maskell N; Lee YCG
Ann Am Thorac Soc; 2017 Jun; 14(6):929-936. PubMed ID: 28324671
[TBL] [Abstract][Full Text] [Related]
8. Short-course intrapleural alteplase and DNase in complex effusion with bleeding risk.
Cheong XK; Yu-Lin Ban A; Abdul Hamid MF
Respirol Case Rep; 2020 Oct; 8(7):e00648. PubMed ID: 32864139
[TBL] [Abstract][Full Text] [Related]
9. Rethinking the Doses of Tissue Plasminogen Activator and Deoxyribonuclease Administrated Concurrently for Intrapleural Therapy for Complicated Pleural Effusion and Empyema.
Innabi A; Surana A; Alzghoul B; Meena N
Cureus; 2018 Feb; 10(2):e2214. PubMed ID: 30755840
[TBL] [Abstract][Full Text] [Related]
10. Intrapleural alteplase in a patient with complicated pleural effusion.
Walker CA; Shirk MB; Tschampel MM; Visconti JA
Ann Pharmacother; 2003 Mar; 37(3):376-9. PubMed ID: 12639166
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of intrapleural instillation of alteplase in the management of complicated pleural effusion or empyema.
Thommi G; Nair CK; Aronow WS; Shehan C; Meyers P; McLeay M
Am J Ther; 2007; 14(4):341-5. PubMed ID: 17667208
[TBL] [Abstract][Full Text] [Related]
12. Retrospective analysis of large-dose intrapleural alteplase for complicated pediatric parapneumonic effusion and empyema.
Taylor JL; Liu M; Hoff DS
J Pediatr Pharmacol Ther; 2015; 20(2):128-37. PubMed ID: 25964730
[TBL] [Abstract][Full Text] [Related]
13. Can intrapleural alteplase treatment be an alternative to videothoracoscopic deloculation and decortication in pleural empyema?
Kermenli T; Azar C
Wideochir Inne Tech Maloinwazyjne; 2021 Sep; 16(3):580-586. PubMed ID: 34691309
[TBL] [Abstract][Full Text] [Related]
14. Combined intrapleural alteplase and DNase therapy in complicated pleural infection arising from postsurgery oesophageal leak.
Ng BH; Nik Abeed NN; Ban AY; Abdul Hamid MF
BMJ Case Rep; 2023 Aug; 16(8):. PubMed ID: 37591627
[TBL] [Abstract][Full Text] [Related]
15. Alteplase and DNase for the treatment of pleural empyema in rats.
Gehlen M; Fraga JC; Amantea SL; Silveira NP; Kulczynski J; Roesch E; Portal KG; Sanches PR
Pulm Pharmacol Ther; 2019 Apr; 55():1-4. PubMed ID: 30648619
[TBL] [Abstract][Full Text] [Related]
16. Intrapleural Fibrinolysis with Urokinase Versus Alteplase in Complicated Parapneumonic Pleural Effusions and Empyemas: A Prospective Randomized Study.
Alemán C; Porcel JM; Alegre J; Ruiz E; Bielsa S; Andreu J; Deu M; Suñé P; Martínez-Sogués M; López I; Pallisa E; Schoenenberger JA; Bruno Montoro J; de Sevilla TF
Lung; 2015 Dec; 193(6):993-1000. PubMed ID: 26423784
[TBL] [Abstract][Full Text] [Related]
17. Use of carefully titrated ultra-low doses of alteplase in infected haemothorax caused by initial alteplase use to drain loculated malignant pleural effusion.
Oh JS; Yoo C; Wong D
Respirol Case Rep; 2023 Sep; 11(9):e01202. PubMed ID: 37577412
[TBL] [Abstract][Full Text] [Related]
18. Predictive Variables for Failure in Administration of Intrapleural Tissue Plasminogen Activator/Deoxyribonuclease in Patients With Complicated Parapneumonic Effusions/Empyema.
Khemasuwan D; Sorensen J; Griffin DC
Chest; 2018 Sep; 154(3):550-556. PubMed ID: 29425674
[TBL] [Abstract][Full Text] [Related]
19. A double blind randomized cross over trial comparing rate of decortication and efficacy of intrapleural instillation of alteplase vs placebo in patients with empyemas and complicated parapneumonic effusions.
Thommi G; Shehan JC; Robison KL; Christensen M; Backemeyer LA; McLeay MT
Respir Med; 2012 May; 106(5):716-23. PubMed ID: 22398159
[TBL] [Abstract][Full Text] [Related]
20. Intrapleural alteplase and DNase for complex tuberculous pleurisy: a medical approach.
Cheong XK; Abdul Hamid MF
Respirol Case Rep; 2021 Feb; 9(2):e00706. PubMed ID: 33425359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
